QYLD vs SCHA
Global X Nasdaq 100 Covered Call ETF vs Schwab US Small-Cap ETF
- • SCHA has the lower expense ratio at 0.03% vs 0.60% for QYLD.
- • QYLD pays a higher dividend yield (5.97%).
Side-by-side metrics
| Metric | QYLD | SCHA |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.60% | 0.03% |
Dividend yield Trailing 12-month yield. | 5.97% | 1.12% |
AUM Assets under management — bigger funds are typically more liquid. | $8.20B | $22.04B |
YTD return | 10.56% | 18.09% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.47 | 1.23 |
P/E ratio | 28.74 | 16.37 |
Last price | $18.06 | $33.55 |
Inception | — | — |
Issuer | Global X | Schwab |
QYLD top holdings
| AAPL | Apple Inc | 8.24% |
| NVDA | NVIDIA Corp | 8.08% |
| MSFT | Microsoft Corp | 6.35% |
| MU | Micron Technology Inc | 4.52% |
| AMZN | Amazon.com Inc | 4.25% |
| AMD | Advanced Micro Devices Inc | 3.73% |
| TSLA | Tesla Inc | 3.44% |
| META | Meta Platforms Inc Class A | 3.00% |
| WMT | Walmart Inc | 2.72% |
| GOOGL | Alphabet Inc Class A | 2.69% |
SCHA top holdings
| HALO | Halozyme Therapeutics Inc | 0.36% |
| GKOS | Glaukos Corp | 0.34% |
| W | Wayfair Inc Class A | 0.32% |
| BMNR | BitMine Immersion Technologies Inc | 0.29% |
| AHR | American Healthcare REIT Inc Ordinary Shares | 0.28% |
| BTSG | BrightSpring Health Services Inc | 0.27% |
| R | Ryder System Inc | 0.26% |
| VSAT | Viasat Inc | 0.26% |
| ENSG | Ensign Group Inc | 0.25% |
| WTFC | Wintrust Financial Corp | 0.25% |
About QYLD
QYLD (Global X Nasdaq 100 Covered Call ETF) is Nasdaq-100 covered call income strategy. Managed by Global X, the fund carries $8.2B in assets under management, an expense ratio of 0.60%, a dividend yield of 5.97%. Its largest holding is Apple Inc (AAPL), which represents 8.2% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 11.0%.
About SCHA
SCHA (Schwab US Small-Cap ETF) is US small-cap equities. Managed by Schwab, the fund carries $22.0B in assets under management, an expense ratio of 0.03%, a dividend yield of 1.12%. Its largest holding is Halozyme Therapeutics Inc (HALO), which represents 0.4% of the portfolio. Real Estate is the fund's largest sector exposure at 6.9%.